MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$200,411K
Net Income
$8,536K
Net Profit Margin
4.26%
EPS
$0.02
Unit: Thousand (K) dollars
Revenue Breakdown
Prescription Transactions Revenu...
Pharma Manufacturer Solutions Re...
Subscription Revenue
Other Revenue
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
200,411
194,006
194,785
196,028
Cost of revenue, exclusive of depreciation and amortization presented separately below
20,999
20,156
17,464
13,419
Product development and technology
26,711
30,177
28,939
31,012
Sales and marketing
81,986
81,053
78,616
83,532
General and administrative
24,814
26,819
23,937
32,014
Depreciation and amortization
22,269
21,792
23,146
21,431
Total costs and operating expenses
176,779
179,997
172,102
181,408
Operating income
23,632
14,009
22,683
14,620
Other income
625
-
24*
0
Loss on extinguishment of debt
-
-
0*
0
Interest income
1,019
1,397
1,889
2,309
Interest expense
9,810
9,767
10,403
10,829
Total other expense, net
-8,166
-8,370
-8,490
-8,520
Income before income taxes
15,466
5,639
14,193
6,100
Income tax expense
6,930
4,470
8,768
4,981
Net income
8,536
1,169
5,425
1,119
Basic EPS
0.03
0
0.016
0
Diluted EPS
0.02
0
0.016
0
Basic Average Shares
339,277,000
340,531,000
342,713,000
346,776,000
Diluted Average Shares
348,058,000
341,424,000
343,267,000
347,810,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Prescription Transactions
Revenue
$106,390K
(-25.63%↓ Y/Y)
Pharma Manufacturer
Solutions Revenues
$61,628K
(76.18%↑ Y/Y)
Subscription Revenue
$28,514K
(39.34%↑ Y/Y)
Other Revenue
$3,879K
(-14.97%↓ Y/Y)
Revenue
$200,411K
(-1.31%↓ Y/Y)
Operating income
$23,632K
(-11.85%↓ Y/Y)
Total costs and
operating expenses
$176,779K
(0.29%↑ Y/Y)
Income before income
taxes
$15,466K
(-21.00%↓ Y/Y)
Total other expense,
net
-$8,166K
(-12.91%↓ Y/Y)
Interest income
$1,019K
(-63.65%↓ Y/Y)
Other income
$625K
(-9.94%↓ Y/Y)
Sales and marketing
$81,986K
(-3.40%↓ Y/Y)
Product development and
technology
$26,711K
(-10.76%↓ Y/Y)
General and
administrative
$24,814K
(-12.56%↓ Y/Y)
Depreciation and
amortization
$22,269K
(12.87%↑ Y/Y)
Cost of revenue,
exclusive of depreciation...
$20,999K
(57.30%↑ Y/Y)
Net income
$8,536K
(-33.54%↓ Y/Y)
Income tax expense
$6,930K
(2.91%↑ Y/Y)
Interest expense
$9,810K
(-8.57%↓ Y/Y)
Buy us a coffee
GoodRx Holdings, Inc. (GDRX)
GoodRx Holdings, Inc. (GDRX)